Equites Radar

MET · MetLife, Inc.

Insurance - LifeUnited StatesAnalyst view: Buy

$94.83

+2.42% last session

End-of-day data · updated 2026-07-28

Bullish5 bullish · 1 bearish technical signals
Consensus: Buy (1.94 from 16 analysts)
To mean target: +3.1%

Market cap

$61B

Enterprise value

$83B

Trailing P/E

18.4

Forward P/E

8.7

Dividend yield

3.0%

Beta

0.78

Avg volume

4M

Employees

46K

2D change

5D change

2.86%

10D change

1.27%

30D change

10.75%

60D change

15.12%

MTD change

9.16%

YTD change

22.38%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.94
Covering analysts16
Mean price target$97.75
Low price target$75.00
Upside to mean target+3.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)72.6
50-day MA$87.20
200-day MA$78.71
Price vs 50-day MA+11.8%
Price vs 200-day MA+23.9%
MACD histogram0.18
Volume vs 3-month avg1.1×
52w low $67.1952w high $97.49

Analyst sentiment over time — MET

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-22

Latest call per bank · past 12 months

JP Morgan

Overweight

$106

+11.8% vs price
▲ raised from $96.00Maintains · 2026-07-21

Jefferies

Buy

$103

+8.6% vs price
▲ raised from $97.00Maintains · 2026-07-10

Wells Fargo

Overweight

$101

+6.5% vs price
▲ raised from $95.00Maintains · 2026-07-09

UBS

Buy

$105

+10.7% vs price
▲ raised from $102Maintains · 2026-07-08

Barclays

Overweight

$94.00

-0.9% vs price
▲ raised from $93.00Maintains · 2026-07-07

Morgan Stanley

Overweight

$103

+8.6% vs price
▲ raised from $93.00Maintains · 2026-07-06

Bank of America

Buy

$99.00

+4.4% vs price
▼ cut from $103Maintains · 2026-04-14

Recent rating actions

DateFirmActionRatingPrice target
2026-07-22TD CowenMaintainsBuy$87.00 $105
2026-07-21JP MorganMaintainsOverweight$96.00 $106
2026-07-13Evercore ISI GroupMaintainsIn-Line$96.00 $103
2026-07-13Keefe, Bruyette & WoodsMaintainsOutperform$98.00 $105
2026-07-10JefferiesMaintainsBuy$97.00 $103
2026-07-09Wells FargoMaintainsOverweight$95.00 $101
2026-07-09MizuhoMaintainsOutperform$95.00 $102
2026-07-08UBSMaintainsBuy$102 $105

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 73 — overbought territory; the recent run-up may be due for a pause.
  • Price vs 50-day MA: Trading 11.8% above the 50-day MA ($87.20).
  • Price vs 200-day MA: Trading 23.9% above the 200-day MA ($78.71).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is positive (+0.18) — short-term momentum is improving.
  • 52-week range: Price is within 5% of the 52-week high ($97.49).

MET Price Chart

Loading chart for MET

Fundamentals

Revenue (TTM)$78B
EBITDA$6.0B
Free cash flow-$17B
Operating cash flow$16B
Book value / share$42.30
Net debt / EBITDA3.7
WACC8.0%
Revenue growth3.00%
Earnings growth36.00%

About MetLife, Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

More in Insurance - Life

Screen MET against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.